» Articles » PMID: 32795172

Mechanism Underlying Increased Cardiac Extracellular Matrix Deposition in Perinatal Nicotine-exposed Offspring

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Although increased predisposition to cardiac fibrosis and cardiac dysfunction has been demonstrated in the perinatally nicotine-exposed heart, the underlying mechanisms remain unclear. With the use of a well-established rat model and cultured primary neonatal rat cardiac fibroblasts, the effect of perinatal nicotine exposure on offspring heart extracellular matrix deposition and the likely underlying mechanisms were investigated. Perinatal nicotine exposure resulted in increased collagen type I (COL1A1) and III (COL3A1) deposition along with a decrease in miR-29 family and an increase in long noncoding RNA myocardial infarction-associated transcript (MIAT) levels in offspring heart. Nicotine treatment of isolated primary neonatal rat cardiac fibroblasts suggested that these effects were mediated via nicotinic acetylcholine receptors including α7 and the induced collagens accumulation was reversed by a gain-of function of miR-29 family. Knockdown of MIAT resulted in increased miR-29 family and decreased COL1A1 and COL3A1 levels, suggesting nicotine-mediated MIAT induction as the underlying mechanism for nicotine-induced collagen deposition. Luciferase reporter assay and RNA immunoprecipitation studies showed an intense physical interaction between MIAT, miR-29 family, and argonaute 2, corroborating the mechanistic link between perinatal nicotine exposure and increased extracellular matrix deposition. Overall, perinatal nicotine exposure resulted in lower miR-29 family levels in offspring heart, while it elevated cardiac MIAT and collagen type I and III levels. These findings provide mechanistic basis for cardiac dysfunction in perinatal nicotine-exposed offspring and offer multiple novel potential therapeutic targets. Using an established rat model and cultured primary neonatal cardiac fibroblasts, we show that nicotine mediated MIAT induction as the underlying mechanism for the excessive cardiac collagen deposition. These observations provide mechanistic basis for the increased predisposition to cardiac dysfunction following perinatal cigarette/nicotine exposure and offer novel potential therapeutic targets.

Citing Articles

Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model.

Chuang T, Ton N, Manrique N, Rysling S, Khorram O Clin Sci (Lond). 2024; 138(12):699-709.

PMID: 38817011 PMC: 11166562. DOI: 10.1042/CS20240190.


Association of Gene Polymorphisms with Risk of Acute Coronary Syndrome in South Indian Population: A Case-Control Genetic Association Study.

Abirami S, Adole P, Vinod K Genet Test Mol Biomarkers. 2024; 28(3):114-122.

PMID: 38471098 PMC: 10979666. DOI: 10.1089/gtmb.2023.0482.


Combination of pioglitazone, a PPARγ agonist, and synthetic surfactant B-YL prevents hyperoxia-induced lung injury in adult mice lung explants.

Kurihara C, Sakurai R, Chuang T, Waring A, Walther F, Rehan V Pulm Pharmacol Ther. 2023; 80:102209.

PMID: 36907545 PMC: 10205668. DOI: 10.1016/j.pupt.2023.102209.


An integral perspective of canonical cigarette and e-cigarette-related cardiovascular toxicity based on the adverse outcome pathway framework.

Ding R, Ren X, Sun Q, Sun Z, Duan J J Adv Res. 2022; 48:227-257.

PMID: 35998874 PMC: 10248804. DOI: 10.1016/j.jare.2022.08.012.


MIAT, a potent CVD-promoting lncRNA.

Yang C, Zhang Y, Yang B Cell Mol Life Sci. 2021; 79(1):43.

PMID: 34921634 PMC: 11072732. DOI: 10.1007/s00018-021-04046-8.


References
1.
Kim J, Park C, Hong S, Park S, Rha S, Seo H . Acute and chronic effects of cigarette smoking on arterial stiffness. Blood Press. 2005; 14(2):80-5. DOI: 10.1080/08037050510008896. View

2.
Lv D, Liu J, Zhao C, Sun Q, Zhou Q, Xu J . Targeting microRNAs in Pathological Hypertrophy and Cardiac Failure. Mini Rev Med Chem. 2015; 15(6):475-8. DOI: 10.2174/1389557515666150324124751. View

3.
Tijsen A, Pinto Y, Creemers E . Non-cardiomyocyte microRNAs in heart failure. Cardiovasc Res. 2011; 93(4):573-82. DOI: 10.1093/cvr/cvr344. View

4.
Xiao J, Gao R, Bei Y, Zhou Q, Zhou Y, Zhang H . Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure. Cell Physiol Biochem. 2017; 41(3):865-874. PMC: 5509048. DOI: 10.1159/000459899. View

5.
Vausort M, Wagner D, Devaux Y . Long noncoding RNAs in patients with acute myocardial infarction. Circ Res. 2014; 115(7):668-77. DOI: 10.1161/CIRCRESAHA.115.303836. View